Acerus Pharmaceuticals Co. (TSE:ASP) Director Luc Mainville bought 97,000 shares of Acerus Pharmaceuticals stock in a transaction on Friday, November 10th. The stock was acquired at an average cost of C$0.14 per share, with a total value of C$13,580.00.

Acerus Pharmaceuticals Co. (TSE ASP) traded up C$0.03 during trading on Tuesday, reaching C$0.16. The company’s stock had a trading volume of 528,899 shares, compared to its average volume of 188,905. Acerus Pharmaceuticals Co. has a 12 month low of C$0.10 and a 12 month high of C$0.16.

WARNING: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at

Receive News & Ratings for Acerus Pharmaceuticals Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals Co. and related companies with's FREE daily email newsletter.